I agree , with IDRA at this level ?? , the shorts will loose ,
On many occasions they play the odds based on statistics & industry ,
Biotech is an industry were shorts like to play with , due to complexity of science without going deeply in DD .
I am sure in IDRA case , they never read reliable Biotech analysts report , never follow up on management seriousness and profile